WallStreetZenWallStreetZen

NASDAQ: RDNT
Radnet Inc Stock

$48.66+0.17 (+0.35%)
Updated Mar 28, 2024
RDNT Price
$48.66
Fair Value Price
-$17.13
Market Cap
$3.33B
52 Week Low
$24.24
52 Week High
$49.41
P/E
973.2x
P/B
5.28x
P/S
1.37x
PEG
1.25x
Dividend Yield
N/A
Revenue
$1.62B
Earnings
$3.04M
Gross Margin
13.7%
Operating Margin
4.7%
Profit Margin
0.2%
Debt to Equity
2.98
Operating Cash Flow
$221M
Beta
1.34
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

RDNT Overview

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RDNT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RDNT ($48.66) is overvalued by 383.99% relative to our estimate of its Fair Value price of -$17.13 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
RDNT ($48.66) is not significantly undervalued (383.99%) relative to our estimate of its Fair Value price of -$17.13 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
RDNT ($48.66) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more RDNT due diligence checks available for Premium users.

Be the first to know about important RDNT news, forecast changes, insider trades & much more!

RDNT News

Valuation

RDNT fair value

Fair Value of RDNT stock based on Discounted Cash Flow (DCF)
Price
$48.66
Fair Value
-$17.13
Undervalued by
383.99%
RDNT ($48.66) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
RDNT ($48.66) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
RDNT ($48.66) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RDNT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
973.2x
Industry
37.37x
Market
44.51x
RDNT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RDNT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

RDNT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.28x
Industry
4.38x
RDNT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RDNT price to earnings growth (PEG)

For valuing profitable companies with growth potential
RDNT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

RDNT's financial health

Profit margin

Revenue
$420.4M
Net Income
-$1.9M
Profit Margin
-0.4%
RDNT's Earnings (EBIT) of $76.00M... subscribe to Premium to read more.
Interest Coverage Financials
RDNT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.7B
Liabilities
$1.9B
Debt to equity
2.98
RDNT's short-term assets ($579.28M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RDNT's long-term liabilities ($1.44B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RDNT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RDNT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$88.9M
Investing
-$48.6M
Financing
-$35.5M
RDNT's operating cash flow ($220.86M)... subscribe to Premium to read more.
Debt Coverage Financials

RDNT vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
RDNT$3.33B+0.35%973.20x5.28x
SHC$3.40B+1.18%66.72x7.66x
NEOG$3.42B+2.07%225.43x1.09x
OLK$2.92B-0.38%-94.04x5.82x
GH$2.51B+14.87%-4.82x15.82x

Radnet Stock FAQ

What is Radnet's quote symbol?

(NASDAQ: RDNT) Radnet trades on the NASDAQ under the ticker symbol RDNT. Radnet stock quotes can also be displayed as NASDAQ: RDNT.

If you're new to stock investing, here's how to buy Radnet stock.

What is the 52 week high and low for Radnet (NASDAQ: RDNT)?

(NASDAQ: RDNT) Radnet's 52-week high was $49.41, and its 52-week low was $24.24. It is currently -1.52% from its 52-week high and 100.74% from its 52-week low.

How much is Radnet stock worth today?

(NASDAQ: RDNT) Radnet currently has 68,475,443 outstanding shares. With Radnet stock trading at $48.66 per share, the total value of Radnet stock (market capitalization) is $3.33B.

Radnet stock was originally listed at a price of $0.60 in Dec 31, 1997. If you had invested in Radnet stock at $0.60, your return over the last 26 years would have been 8,010%, for an annualized return of 18.42% (not including any dividends or dividend reinvestments).

How much is Radnet's stock price per share?

(NASDAQ: RDNT) Radnet stock price per share is $48.66 today (as of Mar 28, 2024).

What is Radnet's Market Cap?

(NASDAQ: RDNT) Radnet's market cap is $3.33B, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Radnet's market cap is calculated by multiplying RDNT's current stock price of $48.66 by RDNT's total outstanding shares of 68,475,443.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.